HomeBREAKING NEWSVimal Elaichi Ad Row: FDA Notices To Shah Rukh Khan, Ajay Devgn...

Vimal Elaichi Ad Row: FDA Notices To Shah Rukh Khan, Ajay Devgn And Tiger Shroff

Maharashtra FDA has questioned three Bollywood stars over a Vimal Elaichi advertisement, alleging it could indirectly promote banned pan masala.

Published on

AI FEED
  • Maharashtra FDA has issued notices to Shah Rukh Khan, Ajay Devgn and Tiger Shroff over a Vimal Elaichi advertisement controversy.
  • The regulator alleges the campaign could amount to surrogate promotion of Vimal Pan Masala, which is prohibited in Maharashtra.
  • The actors have 15 days to submit explanations and documents supporting the independent sale of Vimal Elaichi.

MUMBAI: The Vimal Elaichi advertisement controversy has brought celebrity endorsements under fresh regulatory scrutiny in Maharashtra, with the state’s Food and Drug Administration issuing show-cause notices to Shah Rukh Khan, Ajay Devgn and Tiger Shroff.

The regulator has questioned their participation in a Vimal Elaichi campaign, alleging that the advertisement could create an association with Vimal Pan Masala, a product containing prohibited substances under Maharashtra’s food safety restrictions.

The notices turn the spotlight on a recurring advertising issue, where a product presented as a permissible alternative can potentially reinforce the visibility of a restricted brand or product category.

Vimal Elaichi Advertisement Controversy Triggers FDA Action

According to the Maharashtra FDA notice dated August 11, the use of the name “Vimal Elaichi” in the advertisement appeared to associate the campaign with the Vimal Pan Masala brand.

The regulator has alleged that such an association could mislead consumers and indirectly promote a prohibited product. The three actors have been identified as brand endorsers and have been asked to respond within 15 days of receiving the notices.

The FDA has also asked them to provide documentary evidence establishing that Vimal Elaichi is a separate product that is independently available in the market.

Vimal Elaichi Advertisement Controversy: Actors Asked to Remove Promotions

The actors have been directed to stop participating in or endorsing the advertisement immediately.

The regulator has also asked for the promotional material to be removed from official social media accounts, websites and other digital platforms under their control.

If the actors fail to respond within the prescribed period, or if their explanations are considered unsatisfactory, the administration has warned that further action could be taken without issuing another notice.

Maharashtra Pan Masala Ban Behind Regulatory Action

Maharashtra has prohibited gutka and pan masala containing tobacco or nicotine since 2012 under the Food Safety and Standards Act. The prohibition has been renewed periodically, with the latest order issued by the state food safety commissioner on July 13.

The latest action against the actors comes amid wider enforcement by the Maharashtra FDA. The department has been conducting checks involving adulterated milk and restaurant food, junk food sales near schools and the manufacture and sale of banned gutka and tobacco-containing pan masala.

The case also raises a wider question for the advertising industry: whether celebrity campaigns for seemingly permissible products can indirectly strengthen the brand identity of products that are prohibited.

For the three actors, the immediate issue is to respond to the FDA’s allegations and establish the nature and independent market status of Vimal Elaichi. The regulator’s next decision will depend on the explanations and evidence submitted within the 15-day window.

You May Like

Trending Searches Today |

Amazon Online Shopping

Share Market

Jio Platforms IPO: Price Band, Dates and Key Details

Jio Platforms IPO opens October 21, 2026, with a price band of ₹1,065 to ₹1,119 per share. Check the issue size, key dates and business outlook.

Sensex, Nifty Recover as FMCG, Energy and Banks Lead Gains

Sensex rose 472 points and Nifty gained 133 points on Monday as FMCG, energy and banking stocks led a broad market recovery.

More like this

PM-SETU Approves ₹1,194 Crore for ITI Clusters in Odisha

PM-SETU approves around ₹1,194 crore for five ITI clusters in Maharashtra, Odisha and Jammu and Kashmir, taking total approved investment beyond ₹3,687 crore.

Odisha CM Approves ₹56.55 Crore for Sarpanch And Naib Sarpanch Honorariums

Odisha approves ₹56.55 crore for six months of Sarpanch and Naib Sarpanch honorariums from April to September 2026. Check monthly payment rates.

Reliance Welcomes Starlink as Elon Musk Questions India Entry

Reliance welcomes Starlink competition in India as Elon Musk questions regulatory barriers. Jio also awaits clearances for satellite internet services.